BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even ...

Looking ahead to 2025, Globus Medical has provided guidance that reflects both its standalone operations and the impact of its recent acquisition of Nevro Corp (NYSE:NVRO). The company expects net ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even if ...

Analysts have expressed concerns over the integration of Nevro Corp., which is expected to be more dilutive to earnings than initially forecasted. Despite the challenges, Globus Medical has maintained ...